Clinical trials

  • GIROCTOCOGENE FITELPARVOVEC for Hemophilia A|Moderately severe to severe hemophilia A
  • Sacituzumab govitecan for Endometrial cancer (recurrent or persistent)
  • apixaban for Short bowel syndrome
  • Durvalumab for Metastatic non-small cell lung cancer | Non-small cell lung cancer stage IV
  • [AL[18F]F]FAPI-74 for Oesophagogastric adenocarcinoma | Pancreatic ductal adenocarcinoma | Other solid malignancies (clinically challenging cases)
  • MOTIXAFORTIDE for Multiple myeloma
  • Glycerol phenylbutyrate for Pyruvate dehydrogenase deficiency
  • Icosapent ethyl for Acute myocardial infarction
  • PEMBROLIZUMAB for Metastatic colorectal cancer | MSI-H/dMMR colorectal cancer | BRAF V600E-mutant colorectal cancer
  • BARICITINIB for Calcium pyrophosphate deposition disease|Calcium pyrophosphate dihydrate deposition disease
  • (2R,4R)-1-(3-CHLORO-2-FLUOROBENZYL)-4-((3-FLUORO-6-((5-METHYL-1H-PYRAZOL-3-YL)AMINO)PYRIDIN-2-YL)METHYL)-2-METHYLPIPERIDINE-4-CARBOXYLIC ACID for Neuroblastoma
  • Temozolomide for Brain stem glioma|Malignant glioma